[Ip-health] MSF responds to the outcome of the Global Technical Consultative Meeting on Identification of Health R&D Demonstration Project

Michelle French Michelle.French at newyork.msf.org
Fri Dec 6 08:29:07 PST 2013


MSF responds to the outcome of the Global Technical Consultative Meeting 
on Identification of Health R&D Demonstration Project

http://www.msfaccess.org/content/msf-responds-outcome-global-technical-consultative-meeting-identification-health-rd 


On December 4-5, WHO held a Global Technical Consultative Meeting on 
Identification of Health R&D Demonstration Projects to select the final 
list of projects to be taken forward to WHO Executive Board and World 
Health Assembly in January and May 2014.  The group considered 22 projects 
that had been recommended by WHO member states through a regional 
selection process. 
Two proposals submitted by MSF, one on developing new tuberculosis 
regimens, and a second on developing a multiplex, open source fever 
diagnostic, were included in the shortlist of 22 projects, but were 
ultimately not selected to be taken forward.  Although MSF was 
disappointed with this outcome, it is not our primary concern.  MSF is 
primarily concerned that the process has failed to achieve the fundamental 
and principal mandate of this initiative and of the larger Consultative 
Expert Working Group on Research and Development: Financing and 
Coordination (CEWG) process, which is to test new models of innovation 
that challenge the status quo, and, for example, incorporate the 
principles of open innovation and de-linkage.
Statement from Rohit Malpani, Director of Policy and Analysis for MSF’s 
Access Campaign: 
“MSF doctors in the field witness everyday how the medical innovation 
system is failing to meet many urgent health needs. This process was meant 
to be one step towards addressing that failure, and its particularly 
alarming to see that it has gone so dramatically off-track.
What we wanted was the first stepping stones for change, namely projects 
that fulfilled the mandate of the CEWG to test new models of innovation. 
We are therefore disappointed that the process actually failed to 
prioritize critical recommendations of the CEWG relating to new models of 
innovation as primary criteria for consideration.
It is therefore unclear whether WHO’s attempts to work backwards and fix 
the projects that have been selected is an appropriate approach.  MSF 
calls for Member States and WHO, building upon the efforts of the Expert 
Committee and prior to the 2014 WHA, to put delinkage and transformative 
models of innovation back into the heart of the process.”

###
Michelle French
Communications Officer
Médecins Sans Frontières (MSF) - Access Campaign
Office: +1.212.763.5735 | Mobile: +1.646.552.4600
michelle.french at newyork.msf.org | Skype: michellejfrench
www.msfaccess.org | twitter.com/MSF_access | www.facebook.com/MSFaccess



More information about the Ip-health mailing list